A-228839

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameA-228839

Drug Alias NameA-228839ABT-839A-228839.25 (sulfate)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtein farnesyltransferase inhibitors

TargetsProtein farnesyltransferase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAbbvie Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAbbvie Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A